Daehan New Pharm Co. Ltd (054670) - Total Liabilities

Latest as of September 2025: ₩122.10 Billion KRW ≈ $82.74 Million USD

Based on the latest financial reports, Daehan New Pharm Co. Ltd (054670) has total liabilities worth ₩122.10 Billion KRW (≈ $82.74 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Daehan New Pharm Co. Ltd to track the company's year-over-year net asset growth rate.

Daehan New Pharm Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Daehan New Pharm Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Daehan New Pharm Co. Ltd (054670) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Daehan New Pharm Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Daehan New Pharm Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Elicio Therapeutics Inc. NASDAQ:ELTX	USA	$24.13 Million
Immutep Limited F:YP1A	Germany	€48.30 Million
Boom Logistics Ltd AU:BOL	Australia	AU$145.55 Million
Beyaz Filo Oto Kiralama AS IS:BEYAZ	Turkey	TL4.10 Billion
Chang Type Industrial Co Ltd TW:1541	Taiwan	NT$1.26 Billion
Kamat Hotels (I) Limited NSE:KAMATHOTEL	India	Rs3.48 Billion
XTPL SA WAR:XTP	Poland	zł27.19 Million
Prinsiri Public Company Limited BK:PRIN	Thailand	฿6.90 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Daehan New Pharm Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Daehan New Pharm Co. Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.94	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.49	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Daehan New Pharm Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Daehan New Pharm Co. Ltd (2014–2024)

The table below shows the annual total liabilities of Daehan New Pharm Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩95.85 Billion ≈ $64.95 Million	+41.84%
2023-12-31	₩67.57 Billion ≈ $45.79 Million	+1.76%
2022-12-31	₩66.40 Billion ≈ $45.00 Million	-11.68%
2021-12-31	₩75.18 Billion ≈ $50.95 Million	-1.01%
2020-12-31	₩75.95 Billion ≈ $51.47 Million	+13.62%
2019-12-31	₩66.84 Billion ≈ $45.30 Million	+1.80%
2018-12-31	₩65.66 Billion ≈ $44.49 Million	-6.33%
2017-12-31	₩70.09 Billion ≈ $47.50 Million	+17.77%
2016-12-31	₩59.52 Billion ≈ $40.33 Million	+7.38%
2015-12-31	₩55.43 Billion ≈ $37.56 Million	-2.03%
2014-12-31	₩56.58 Billion ≈ $38.34 Million	--

About Daehan New Pharm Co. Ltd

KQ:054670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$53.26 Million

₩78.60 Billion KRW

Market Cap Rank

#21578 Global

#1248 in Korea

Share Price

₩5600.00

Change (1 day)

+3.90%

52-Week Range

₩5090.00 - ₩7510.00

All Time High

₩21012.38